Schedule meeting @ ASCO 2018
Predicine is a global precision medicine company that has developed patented Gene RADAR technology, an RNA- and DNA-based liquid biopsy test for early cancer detection, disease monitoring and assessing minimal residual disease. With its integrated biomarker platform, vast data sets and advanced analytics, Predicine has partnered with 30+ biopharmas to support their clinical trials in US, EU, Australia and China. Predicine operates in US and China.
Stop by booth #2119 to learn more or submit your information below to request a meeting.
Schedule a meeting with us!
1. Detection, dynamic monitoring, and resistance mechanism exploration of genomic alterations in circulating cell free tumor DNA (ctDNA) in Chinese metastatic breast cancer (mBC)
Biomarker-Driven Immuno-oncology Symposium
June 2, 6:30pm
Hyatt Regency McCormick Place